SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO)

Historical Holders from Q3 2022 to Q1 2025

Symbol
SLNO on Nasdaq
CUSIP
834203309
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
46M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
51M
Holdings value
$2.29B
% of all portfolios
0.011%
Grand Portfolio weight change
+0%
Number of holders
169
Number of buys
115
Number of sells
-48
Average Value change %
0%
Average buys %
+0.004%
Average sells %
-0.007%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 12% $371M 5.19M JANUS HENDERSON GROUP PLC Dec 31, 2024
Vivo Opportunity Fund Holdings, L.P. 9.7% $319M 4.46M Vivo Opportunity Fund Holdings, L.P. Mar 31, 2025
Nantahala Capital Management, LLC 9.99% 0% $311M $28.4M 4.35M +10.1% Nantahala Capital Management, LLC Dec 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.44% $198M 2.78M Adage Capital Management, L.P. Dec 31, 2024
BlackRock, Inc. 4.7% $144M 2.01M BlackRock, Inc. Dec 31, 2024

Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 540K $38.6M +$32M $71.45 11
2024 Q4 51M $2.29B +$170M $44.95 169
2024 Q3 47.1M $2.38B +$200M $50.49 141
2024 Q2 43.3M $1.77B +$339M $40.80 112
2024 Q1 35M $1.5B +$151M $42.80 100
2023 Q4 31.4M $1.26B +$428M $40.25 76
2023 Q3 20.3M $599M +$451M $29.51 54
2023 Q2 4.85M $20.8M +$7.84M $4.29 22
2023 Q1 3.07M $6.54M +$3.16M $2.14 20
2022 Q4 2.79M $5.52M +$81.6K $1.98 22
2022 Q3 2.78M $4.64M +$4.63M $1.67 12